EMEA-001590-PIP01-13-M04

Key facts

Active substance
Allantoin
Therapeutic area
Dermatology
Decision number
P/0225/2017
PIP number
EMEA-001590-PIP01-13-M04
Pharmaceutical form(s)
Cream
Condition(s) / indication(s)
Treatment of epidermolysis bullosa
Route(s) of administration
Topical use
Contact for public enquiries
Scioderm, Inc. 
United States
Tel. +1 9193 282020
E-mail: info@sdermebtrials.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating